文献速递神经MR

酰胺质子转移与化学交换饱和转移MRI鉴别生长性与非生长性颅内脑膜瘤:一项先导研究

Amide proton transfer and chemical exchange saturation transfer MRI differentiates between growing and non-growing intracranial meningiomas: a pilot study.
PubMed 文献 · Clin Radiol · 2022-01-26

回顾性纳入17例疑似颅内脑膜瘤患者,评估APT-CEST成像的MTR值及常规MRI特征,比较生长性与非生长性脑膜瘤。生长性组MTR值0.0198±0.0003显著高于非生长性组0.0131±0.0002(p<0.0001)。以MTR阈值0.0151行ROC分析,鉴别两组的敏感度100%、特异度85.7%、阳性预测值90.9%、阴性预测值100%。

要点

  • 生长性脑膜瘤MTR值0.0198±0.0003,非生长性0.0131±0.0002,p<0.0001。
  • MTR阈值0.0151鉴别生长与否:敏感度100%、特异度85.7%、阳性预测值90.9%、阴性预测值100%。
  • APT-CEST的MTR值可区分生长性与非生长性颅内脑膜瘤。

核心结论

  • 生长性脑膜瘤患者可依据肿瘤生长后APT-CEST成像的MTR值与非生长性脑膜瘤患者区分。

研究设计与样本

  • 回顾性评估2020年11月至2021年4月接受APT-CEST MRI的17例疑似颅内脑膜瘤患者,评估APT-CEST成像的MTR值及常规MRI特征,并与既往MRI检查比较,行ROC曲线分析确定MTR诊断截断值。

关键影像表现/征象

  • 生长性脑膜瘤组MTR值0.0198±0.0003,非生长性脑膜瘤组0.0131±0.0002,两组差异显著(p<0.0001)。

诊断标准与关键数值

  • MTR值鉴别生长性与非生长性脑膜瘤的ROC曲线下面积阈值0.0151,敏感度100%、特异度85.7%、阳性预测值90.9%、阴性预测值100%。

临床应用与阅片要点

  • 作者认为,利用肿瘤生长后APT-CEST成像的MTR值可将生长性脑膜瘤患者与非生长性脑膜瘤患者区分。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

AIM: To differentiate between growing and non-growing intracranial meningiomas using magnetisation transfer ratio (MTR) values with amide proton transfer (APT) and chemical exchange saturation transfer (CEST) magnetic resonance imaging (MRI).

MATERIALS AND METHODS: Seventeen patients with suspected intracranial meningiomas who underwent APT-CEST MRI from November 2020 to April 2021 were evaluated retrospectively. MTR values on APT-CEST imaging as well as conventional MRI features were evaluated. These parameters were compared in growing meningiomas versus non-growing meningiomas and the findings compared with previous MRI examinations. ROC curve analysis was also performed to determine the diagnostic cut-offs for MTR.

RESULTS: The cohort comprised 10 patients with growing meningiomas (two men [20%], eight women [80%]; mean age [standard deviation (SD)]: 59.9 years [16]) and seven patients with non-growing meningiomas (seven women [100%]; mean age [SD]: 63.9 years [18.6]). Significant differences were found in MTR values (0.0198 ± 0.0003 versus 0.0131 ± 0.0002; p<0.0001) between the growing meningiomas and non-growing meningiomas groups, respectively. The receiver operating characteristic (ROC) curve analysis showed that MTR values clearly differentiated between growing and non-growing meningiomas. At an area under the ROC curve (AUC) threshold of 0.0151, diagnostic sensitivity, specificity, positive predictive value, and negative predictive values for MTR were 100%, 85.7%, 90.9%, and 100%, respectively.

CONCLUSION: Patients with growing meningiomas could be discriminated from patients with non-growing meningiomas, using the MTR values on post-growth tumour APT-CEST imaging.

来源:Clin Radiol,查看原文。版权归原作者所有。

引用

  1. Koike, Morikawa, Ideguchi, et al. Amide proton transfer and chemical exchange saturation transfer MRI differentiates between growing and non-growing intracranial meningiomas: a pilot study. Clin Radiol. 2022. PMID: 35090693. doi:10.1016/j.crad.2021.12.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。